Sponsor pipeline

Miltenyi Biomedicine GmbH clinical trial pipeline

Get alerts when Miltenyi Biomedicine GmbH's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1
2
Phase 1/2
4
Phase 2
5
Not charted: 4 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 12

Non-Hodgkin Lymphoma (8) · DLBCL (4) · Leukemia (4) · Acute Lymphoblastic Leukemia (ALL) (3) · Lupus (SLE) (3) · Acute Myeloid Leukemia (AML) (2) · Chronic Lymphocytic Leukemia (CLL) (2) · Mantle Cell Lymphoma (2) · Scleroderma (2) · Melanoma (1)

Get alerts when Miltenyi Biomedicine GmbH's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free